Company record
Telesis Bio Inc. designs and manufactures synthetic‑biology instruments, reagents, and software solutions. Its portfolio features automated benchtop platforms that synthesize DNA and mRNA, as well as enzymatic DNA‑synthesis systems paired with dedicated kits. The company’s kit lineup covers DNA cloning, gene synthesis, cell‑free amplification, and library construction. In addition to product sales, Telesis Bio offers custom synthesis and combinatorial library services. These capabilities support drug‑discovery programs, vaccine development, cell‑ and gene‑therapy projects, and antibody‑engineering initiatives.
This directory record does not yet have a linked material-flow brief.